Technical Analysis for LFCR - Lifecore Biomedical, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | -2.71% | |
| Overbought Stochastic | Strength | -2.71% | |
| Bearish Engulfing | Bearish | -0.24% | |
| Stochastic Sell Signal | Bearish | -0.24% | |
| Weak + Overbought | Other | -0.24% | |
| Weak, Overbought and Reversal Signs | Reversal | -0.24% | |
| Overbought Stochastic | Strength | -0.24% | |
| Weak + Overbought | Other | -6.20% | |
| Wide Bands | Range Expansion | -6.20% | |
| Overbought Stochastic | Strength | -6.20% |
| Alert | Time |
|---|---|
| Down 3% | about 2 hours ago |
| Fell Below Previous Day's Low | about 2 hours ago |
| Down 2 % | about 2 hours ago |
| 60 Minute Opening Range Breakdown | about 3 hours ago |
| Down 1% | about 3 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/30/2024
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market.
Sector: Consumer Defensive
Industry: Farm Products
Keywords: Biotechnology Life Sciences Acid Natural Sciences Contract Manufacturing Organization Hyaluronic Acid Glycosaminoglycans Patheon
Classification
Sector: Consumer Defensive
Industry: Farm Products
Keywords: Biotechnology Life Sciences Acid Natural Sciences Contract Manufacturing Organization Hyaluronic Acid Glycosaminoglycans Patheon
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.455 |
| 52 Week Low | 4.1 |
| Average Volume | 214,765 |
| 200-Day Moving Average | 7.58 |
| 50-Day Moving Average | 6.95 |
| 20-Day Moving Average | 6.03 |
| 10-Day Moving Average | 6.31 |
| Average True Range | 0.42 |
| RSI (14) | 51.22 |
| ADX | 14.7 |
| +DI | 23.25 |
| -DI | 21.13 |
| Chandelier Exit (Long, 3 ATRs) | 5.50 |
| Chandelier Exit (Short, 3 ATRs) | 6.24 |
| Upper Bollinger Bands | 6.90 |
| Lower Bollinger Band | 5.17 |
| Percent B (%b) | 0.74 |
| BandWidth | 28.72 |
| MACD Line | -0.05 |
| MACD Signal Line | -0.16 |
| MACD Histogram | 0.1126 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.83 | ||||
| Resistance 3 (R3) | 6.80 | 6.65 | 6.77 | ||
| Resistance 2 (R2) | 6.65 | 6.55 | 6.66 | 6.74 | |
| Resistance 1 (R1) | 6.55 | 6.49 | 6.60 | 6.58 | 6.72 |
| Pivot Point | 6.39 | 6.39 | 6.42 | 6.41 | 6.39 |
| Support 1 (S1) | 6.30 | 6.30 | 6.35 | 6.32 | 6.18 |
| Support 2 (S2) | 6.14 | 6.24 | 6.16 | 6.16 | |
| Support 3 (S3) | 6.04 | 6.14 | 6.13 | ||
| Support 4 (S4) | 6.07 |
